Cognitive impairment in early stages of multiple sclerosis is associated with high cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain

被引:55
|
作者
Quintana, E. [1 ,2 ,3 ]
Coll, C. [1 ]
Salavedra-Pont, J. [1 ]
Munoz-San Martin, M. [1 ]
Robles-Cedeno, R. [1 ,2 ,3 ]
Tomas-Roig, J. [1 ]
Buxo, M. [4 ]
Matute-Blanch, C. [5 ]
Villar, L. M. [2 ,6 ]
Montalban, X. [2 ,5 ]
Comabella, M. [2 ,5 ]
Perkal, H. [1 ]
Gich, J. [1 ,3 ]
Ramio-Torrenta, L. [1 ,2 ,3 ]
机构
[1] Dr Josep Trueta Univ Hosp, Neuroimmunol & Multiple Sclerosis Unit, Girona Biomed Res Inst, IDIBGI,Neurol Dept, Dr Castany S-N, Salt 17190, Girona, Spain
[2] REEM, Madrid, Spain
[3] Univ Girona, Fac Med, Dept Med Sci, Girona, Spain
[4] IDIBGI, Girona Biomed Res Inst, Girona, Spain
[5] Univ Autonoma Barcelona, Serv Neurol Neuroimmunol, Ctr Esclerosi Multiple Catalunya Cemcat, Inst Recerca Vall Hebron,VHIR,Hosp Univ Vall Hebr, Barcelona, Spain
[6] Hosp Ramon & Cajal, Dept Immunol, IRYCIS, Madrid, Spain
关键词
biomarkers; chitinase; 3-like; 1; mild cognitive impairment; multiple sclerosis; neurofilament light chain; MINIMAL ASSESSMENT; BIOMARKERS; TESTS; MS;
D O I
10.1111/ene.13687
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and purpose: Chitinase 3-like 1 (CHI3L1) and neurofilament light chain (NF-L) are promising biomarkers of disability in multiple sclerosis (MS). However, their role in cognitive dysfunction remains elusive. Here, we aimed to correlate cerebrospinal fluid (CSF) levels of CHI3L1 and NF-L with cognitive status in MS. Methods: Fifty one recently diagnosed patients were cognitively evaluated and CSF was collected. Levels of CHI3L1 and NF-L were determined by ELISA. Spearman's partial correlation coefficient was performed. Results: After adjusting cognitive scores by age, anxiety and EDSS, association was detected between CHI3L1 levels and Trail Making Test A (rs = 0.348; p = 0.016) and between NF-L levels and Word List Generation (rs = -0.324; p = 0.025). Conclusion: High levels of CSF CHI3L1 and NF-L are associated with cognitive impairment in the early phases of MS.
引用
收藏
页码:1189 / 1191
页数:3
相关论文
共 50 条
  • [21] Cerebrospinal fluid levels of neurofilament light chain, C-X-C ligand motif 13, and chitinase-3-like protein 1 reflect distinct pathological processes in multiple sclerosis
    Zanoni, M.
    Bongianni, M.
    Poletto, E.
    Turatti, M.
    Calabrese, M.
    Marangi, A.
    Gobbin, F.
    Monaco, S.
    Benedetti, M. D.
    Gajofatto, A.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 837 - 837
  • [22] Cerebrospinal fluid neurofilament light chain is a marker of disease activity in multiple sclerosis
    Poletto, E.
    Zanoni, M.
    Bongianni, M.
    Turatti, M.
    Calabrese, M.
    Marangi, A.
    Gobbin, F.
    Monaco, S.
    Benedetti, D.
    Gajofatto, A.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 290 - 291
  • [23] Chitinase 3-like 1 as potential therapeutic target in multiple sclerosis
    Matute-Blanch, C.
    Carballo-Carbaja, I.
    Navarro, L.
    Montalban, X.
    Comabella, M.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 403 - 404
  • [24] Chitinase 3-like 1 is not a target antigen in patients with multiple sclerosis
    Comabella, Manuel
    Deutschmann, Claudia
    Midaglia, Luciana
    Schierack, Peter
    Martinez, Julia
    Roggenbuck, Dirk
    Montalban, Xavier
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (09) : 1455 - 1457
  • [25] Intrathecal immunoglobulin synthesis and leucocyte count in cerebrospinal fluid predict serum neurofilament light chain levels in early multiple sclerosis
    Engel, S.
    Luessi, F.
    Steffen, F.
    Scholz-Kreisel, P.
    Zipp, F.
    Bittner, S.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 499 - 500
  • [26] Chitinase 3-like 1 plasma levels are increased in patients with progressive forms of multiple sclerosis
    Canto, E.
    Reverter, F.
    Morcillo-Suarez, C.
    Matesanz, F.
    Fernandez, O.
    Izquierdo, G.
    Vandenbroeck, K.
    Rodriguez-Antigueedad, A.
    Urcelay, E.
    Arroyo, R.
    Otaegui, D.
    Olascoaga, J.
    Saiz, A.
    Navarro, A.
    Sanchez, A.
    Dominguez, C.
    Caminero, A.
    Horga, A.
    Tintore, M.
    Montalban, X.
    Comabella, M.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (07) : 983 - 990
  • [27] Cerebrospinal fluid neurofilament light chain as a biomarker for early diagnosis of multiple sclerosis in patients with optic neuritis
    Passali, Moschoula
    Galea, Ian
    Knudsen, Maria Hojberg
    Lau, Laurie
    Cramer, Stig
    Frederiksen, Jette
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 298 - 298
  • [28] Chitinase 3-like 1 is associated with the response to interferon-beta in multiple sclerosis patients
    Matute, C.
    Rio, J.
    Villar, L. M.
    Malhotra, S.
    Alvarez-Cermeno, J. C.
    Montalban, X.
    Comabella, M.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 635 - 635
  • [29] Neurofilament light chain levels in blood are predictive of cognitive impairment in patients with secondary progressive multiple sclerosis
    Kuhle, J.
    Kropshofer, H.
    Barro, C.
    Meinert, R.
    Haring, D.
    Leppert, D.
    Dahlke, F.
    Tomic, D.
    Kappos, L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 666 - 666
  • [30] Chitinase 3-like 1 is associated with the response to interferon-beta treatment in multiple sclerosis
    Matute-Blanch, Clara
    Rio, Jordi
    Villar, Luisa M.
    Midaglia, Luciana
    Malhotra, Sunny
    Alvarez-Cermeno, Jose C.
    Vidal-Jordana, Angela
    Montalban, Xavier
    Comabella, Manuel
    JOURNAL OF NEUROIMMUNOLOGY, 2017, 303 : 62 - 65